CERECOR

Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for immunologic, immuno-oncologic and rare genetic disorders. The company is advancing its clinical-stage pipeline of innovative therapies that address unmet patient needs within rare and orphan diseases. The company's rare disease pipeline includes CERC-801, CERC-802 and CERC-803, which are in development for congenital disorders of glycosylation and CERC-006, an oral mTORc... 1/c2 inhibitor in development for the treatment of complex lymphatic malformations. The company is also developing two monoclonal antibodies, CERC-002, and CERC-007. CERC-002 targets the cytokine LIGHT (TNFSF14) and is in clinical development for treatment of severe pediatric-onset Crohn's disease and COVID-19 acute respiratory distress syndrome. CERC-007 targets the cytokine IL-18 and is in clinical development for the treatment of Stillโs disease (adult onset Stillโs disease (AOSD) and systemic juvenile idiopathic arthritis (sJIA)) and multiple myeloma (MM). CERC-006, 801, 802 and 803 have all received Orphan Drug Designation and Rare Pediatric Disease Designation, which makes all four eligible for a priority review voucher upon FDA approval.
CERECOR
Industry:
Biopharma Biotechnology Health Care
Founded:
2011-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.cerecor.com
Total Employee:
11+
Status:
Active
Contact:
410-522-8707
Email Addresses:
[email protected]
Total Funding:
133.34 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 ReCAPTCHA ASP.NET Amazon Virginia Region ReCAPTCHA V2
Similar Organizations
AcSentient
AcSentient develops and commercializes specialty, niche prescription drugs.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-12-05 | Aevi Genomic Medicine | Aevi Genomic Medicine acquired by Cerecor | 22.6 M USD |
2018-09-25 | Ichorion Therapeutics | Ichorion Therapeutics acquired by Cerecor | 26.6 M USD |
2017-11-17 | Zylera Pharmaceuticals | Zylera Pharmaceuticals acquired by Cerecor | N/A |
Investors List
Horizon Technology Finance
Horizon Technology Finance investment in Post-IPO Debt - Cerecor
Horizon Technology Finance
Horizon Technology Finance investment in Post-IPO Debt - Cerecor
National Institutes of Health
National Institutes of Health investment in Grant - Cerecor
MPM Capital
MPM Capital investment in Series B - Cerecor
Apple Tree Partners
Apple Tree Partners investment in Series B - Cerecor
New Enterprise Associates
New Enterprise Associates investment in Series B - Cerecor
Official Site Inspections
http://www.cerecor.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Cerecor"
Cerecor - Crunchbase Company Profile & Funding
Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for immunologic, immuno-oncologic and rare genetic โฆSee details»
About CereCore
When an organization is expanding and adding new facilities, CereCore can support that growth. Outsourcing the help desk to them has allowed us to focus on things like our root cause โฆSee details»
Cerecor, Inc. Information - RocketReach
Cerecor Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in the human โฆSee details»
Cerecor - 2025 Company Profile, Funding & Competitors - Tracxn
May 31, 2025 Cerecor has raised a total funding of $45.2M over 6 rounds. Its first funding round was on Apr 04, 2012. Its latest funding round was a Post IPO round on Apr 28, 2017 for $5M. โฆSee details»
Cerecor and Aevi Genomic Medicine Complete Merger
Cerecor seeks to initiate a pivotal study for one or more CERC-800 program(s) in 2020, with the first anticipated NDA filing in 2021. About Cerecor . Cerecor is a biopharmaceutical company โฆSee details»
Cerecor: Revenue, Worth, Valuation & Competitors 2025
About Cerecor. Cerecor is a Biotech related company with 33 employees an estimated revenue of $2.6M, and. It has 10 competitors including Dermavant Sciences, Metrum Research Group โฆSee details»
Cerecor - VentureRadar
Cerecor Inc. ('Cerecor') is a Baltimore-based biopharmaceutical company developing innovative treatments to make a difference in the lives of patients suffering from neuropsychiatric โฆSee details»
Parallon Technology Solutions is Now CereCore
The word โCereCoreโ represents the unique impact the company has empowering caregivers to provide life-saving care. The name is comprised of two terms โฆSee details»
Cerecor - Contacts, Employees, Board Members, Advisors & Alumni
Cerecor discovers, develops and commercializes neuroscience drugs. Experience the new Crunchbase, powered by AISee details»
Avalo Therapeutics, Inc. Announces Corporate Name Change
August 26, 2021 07:30 ET | Source: Cerecor Inc. Cerecor Inc. Name change underscores the Companyโs transition to developing innovative targeted therapies in immunology, immuno โฆSee details»
Cerecor Announces Drawdown of $10 Million Tranche under its โฆ
Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for immunologic, immuno-oncologic and rare genetic โฆSee details»
Leadership Team :: Avalo Therapeutics, Inc. (AVTX)
Dr. Neil serves as Chief Executive Officer at Avalo Therapeutics (formerly Cerecor, Inc.), a publicly held biotechnology company since February 2022. ... Under his leadership, his teams โฆSee details»
Cerecor Reports 2020 Financial Results and Provides Business โฆ
Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases. The company is advancing its โฆSee details»
Cerecor - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Apr 27, 2025 The intellectual property of Cerecor includes 6 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. Additionally, โฆSee details»
Cerecor - Funding, Financials, Valuation & Investors - Crunchbase
Cerecor is registered under the ticker NASDAQ:CERC . Cerecor is funded by 6 investors. Horizon Technology Finance and Horizon Technology Finance are the most recent investors. Cerecor โฆSee details»
Leadership and History | CereCore
Leadership with Healthcare Experience CereCore has hundreds of experts working across the nation with backgrounds in healthcare operations, clinical applications, technology, and data โฆSee details»
What is Cerecor? Company Culture, Mission, Values | Glassdoor
See what employees say it's like to work at Cerecor. Salaries, reviews, and more - all posted by employees working at Cerecor.See details»
CereCore 2025 Company Profile: Overview & Executives - PitchBook
CereCore General Information Description. Provider of information technology services intended to aid the healthcare industry based out of United States. The company's offerings include โฆSee details»
Working At Cerecor: Company Overview and Culture - Zippia
Learn about working at Cerecor from employee reviews and detailed data on culture, salaries, demographics, management, financial, and more. Find out what it's like to work at Cerecor. โฆSee details»
Cerecor Announces Changes to Board of Directors - GlobeNewswire
Apr 24, 2020 These statements are based upon the current beliefs and expectations of Cerecorโs management but are subject to significant risks and uncertainties, including: reliance โฆSee details»